Article thumbnail
Location of Repository

Polyclonal B Cell Differentiation and Loss of Gastrointestinal Tract Germinal Centers in the Earliest Stages of HIV-1 Infection

By Marc C. Levesque, M. Anthony Moody, Kwan-Ki Hwang, Dawn J. Marshall, John F. Whitesides, Joshua D. Amos, Thaddeus C. Gurley, Sallie Allgood, Benjamin B. Haynes, Nathan A. Vandergrift, Steven Plonk, Daniel C. Parker, Myron S. Cohen, Georgia D. Tomaras, Paul A. Goepfert, George M. Shaw, Jörn E. Schmitz, Joseph J. Eron, Nicholas J. Shaheen, Charles B. Hicks, Hua-Xin Liao, Martin Markowitz, Garnett Kelsoe, David M. Margolis and Barton F. Haynes


Studying the effects of early HIV infection on human antibody responses, M. Anthony Moody and colleagues find rapid polyclonal B cell differentiation and structural damage to gut-associated lymphoid tissue

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2009). A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.
  2. (1996). A monoclonal IgG anticardiolipin antibody from a patient with the antiphospholipid syndrome is thrombogenic in mice.
  3. (1983). Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.
  4. (1991). Activation of cytotoxic cells in hyperplastic lymph nodes from HIV-infected patients.
  5. (2009). Adaptive immune features of natural killer cells. Nature 457: 557–561. HIV-1-Induced GALT Germinal Center Loss PLoS Medicine |
  6. (1995). Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden.
  7. (1999). Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.
  8. (2003). Antibody neutralization and escape by HIV-1.
  9. (1995). Antigen-induced B-cell death and elimination during germinal-centre immune responses.
  10. (2003). Antigen-specific Blymphocyte activation.
  11. (2008). B cell-directed therapies for autoimmune disease and correlates of disease response and relapse.
  12. (1993). B-cell abnormalities in AIDS: stable and clonally-restricted antibody response in HIV1 infection.
  13. (2001). Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjo ¨gren’s syndrome.
  14. (2004). CD4 + T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract.
  15. (1998). CD4 +-T-cell and CD20 +-B-cell changes predict rapid disease progression after simian-human immunodeficiency virus infection in macaques.
  16. (2005). Cellular and genetic mechanisms of self tolerance and autoimmunity.
  17. (1995). Cellular interaction in germinal centers. Roles of CD40 ligand and B7-2 in established germinal centers.
  18. (1996). Clonal selection and learning in the antibody system.
  19. (2009). Cytokineinduced memory-like natural killer cells.
  20. (2004). Defensins: natural anti-HIV peptides.
  21. (1998). Determinants of disease in the simian immunodeficiency virus-infected rhesus macaque: characterizing animals with low antibody responses and rapid progression.
  22. (2007). Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide.
  23. (2007). Duration of humoral immunity to common viral and vaccine antigens.
  24. (2007). Early depletion of proliferating B cells of germinal center in rapidly progressive simian immunodeficiency virus infection.
  25. (1995). Early human T cell development: analysis of the human thymus at the time of initial entry of hematopoietic stem cells into the fetal thymic microenvironment.
  26. (2006). Elimination of chronic viral infection by blocking CD27 signaling.
  27. (1989). Epstein-Barr virus preferentially induces proliferation of primed B cells.
  28. (2007). Evolution of innate and adaptive effector cell functions during acute HIV-1 infection.
  29. (1989). Follicular dendritic cells in HIVinduced lymphadenopathy and AIDS.
  30. (1998). Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection.
  31. (1998). HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy.
  32. (2006). HIV-1 envelope triggers polyclonal Ig class switch recombination through a CD40-independent mechanism involving BAFF and C-type lectin receptors.
  33. (2001). HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals.
  34. (2004). Human blood IgM ‘‘memory’’ B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.
  35. (1992). Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation.
  36. (2000). Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection.
  37. (1993). Immunoglobulin VH3 gene products: natural ligands for HIV gp120.
  38. (2002). Immunohistochemical recognition of human follicular dendritic cells (FDCs) in routinely processed paraffin sections.
  39. (1995). In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. IV. Affinity-dependent, antigen-driven B cell apoptosis in germinal centers as a mechanism for maintaining self-tolerance.
  40. (2009). Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.
  41. (2008). Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design.
  42. (2008). Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
  43. (1999). Interleukin-15 enhances HIV-1-driven polyclonal B-cell response in vitro.
  44. (2004). Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy.
  45. (2007). Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease.
  46. (2008). Maintenance of serological memory.
  47. (1993). Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells.
  48. (2006). Microbial translocation is a cause of systemic immune activation in chronic HIV infection.
  49. (1987). Monoclonal antibodies to human immunodeficiency virus: their relation to the patterns of lymph node changes in persistent generalized lymphadenopathy and AIDS.
  50. (1993). Multifactorial nature of human immunodeficiency virus disease: implications for therapy.
  51. (2007). Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection.
  52. (2003). New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma.
  53. (2008). Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease.
  54. (2004). Primary HIV-1 infection is associated with preferential depletion of CD4 + T lymphocytes from effector sites in the gastrointestinal tract.
  55. (2005). Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions.
  56. (2008). Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C.
  57. (2000). Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies.
  58. (1996). Quantitative image analysis of HIV-1 infection in lymphoid tissue.
  59. (2003). Rapid evolution of the neutralizing antibody response to HIV type 1 infection.
  60. (2008). Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration.
  61. (2005). Role of cytokines and chemokines in the regulation of innate immunity and HIV infection.
  62. (1994). Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection.
  63. (2005). Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection.
  64. (2003). Severe CD4 + T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy.
  65. (1996). Similar abnormalities of idiotype and immunoglobulin light chain expression and of cellmediated cytotoxicity in HIV-infected humans and simian immunodeficiency virus (SIV)-infected rhesus macaques.
  66. (1995). Soluble antigen can cause enhanced apoptosis of germinal-centre B cells.
  67. (1986). Spectrum of morphologic changes of lymph nodes from patients with AIDS or AIDS-related complexes.
  68. (2002). Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells.
  69. (1998). T-cell independent IgM and enduring protective IgG antibodies induced by chimeric measles viruses.
  70. (2009). The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.
  71. (1973). The immune response to fX 174 in man. I. Primary and secondary antibody production in normal adults.
  72. (1990). The immunohistology of lymph nodes in HIV infection: a review.
  73. (2001). The mucosal immune system: primary target for HIV infection and AIDS.
  74. (1983). The role of epithelial cells in gut-associated immune reactivity.
  75. (1985). The varied histopathology of lymphadenopathy in the homosexual male.
  76. (2003). Transmission, acute HIV-1 infection and the quest for strategies to prevent infection.
  77. (1989). Ultrastructural analysis of germinal centers in lymph nodes of patients with HIV1-induced persistent generalized lymphadenopathy: evidence for persistence of infection.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.